BackGreenLight Biosciences- Warrants (30/09/2027) Overview

GreenLight Biosciences- Warrants (30/09/2027) Total Current Liabilities

Latest total current liabilities for GRNAW: $31M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$31.19M
↑ 5.63% YoYΔ $1.66M vs prior year quarter

Peer trimmed avg / median

Loading

GreenLight Biosciences- Warrants (30/09/2027) Total Current Liabilities History

Loading

GreenLight Biosciences- Warrants (30/09/2027) vs. peers: Total Current Liabilities Comparison

Loading

GreenLight Biosciences- Warrants (30/09/2027) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) FAQ

As of the most recent data (March 2023), GRNAW shows a total current liabilities of $31M. That compares with $30M in the prior-year period — up 5.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNAW's total current liabilities is now $31M (was $30M) — a 5.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences- Warrants (30/09/2027) is outperforming or lagging.

Tracking GRNAW's total current liabilities over time shows whether GreenLight Biosciences- Warrants (30/09/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $31M That compares with $30M in the prior-year period — up 5.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has GreenLight Biosciences- Warrants (30/09/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $31M) with ownership activity and broader fundamentals.